In vivo performance evaluation of a transdermal near- infrared fluorescence resonance energy transfer affinity sensor for continuous glucose monitoring.

The in vivo performance of a transdermal near-infrared fluorescence resonance energy transfer (FRET) affinity sensor was investigated in hairless rats, in order to validate its feasibility for glucose monitoring in humans. The sensor itself consists of a small hollow fiber implanted in dermal skin tissue, containing glucose-sensitive assay chemistry composed of agarose-immobilized Concanavalin A (ConA) and free dextran. The glucose-dependent fluorescence change is based on FRET between near-infrared-compatible donor and quencher dyes that are chemically linked to dextran and ConA, respectively. We conducted an acute in vivo evaluation of transdermal sensors with an optical fiber-coupled setup over 4 h, and a chronic in vivo evaluation of fully implanted sensors for up to 16 days. The fiber-coupled sensors followed trends of blood glucose concentrations very well with a delay of less than 5 min. The acute performance of the implanted sensors at the day of implantation was similar to that of the fiber-coupled sensors. After 2 weeks the implanted sensors remained functional, evidenced by an adequate correlation between sensor signal and changes in blood glucose excursions, but exhibited delays of approximately 10-15 min. Preliminary characterization of host response showed signs of mild inflammations around the implanted sensor, which were characterized by formation of a 10-20-microm-thick collagen band, typical for capsule formation. An acute study of systemic ConA biotoxicity was also conducted. A histological analysis of various organs and of clinical chemistry data showed no significant differences between rats receiving intradermal injections of ConA at 10 times the concentration in the sensor and rats in a control group (injection of saline solution). The absence of a toxicological or systemic response to ConA at a 10-fold larger amount than in the sensor should dispel concerns over the in vivo safety of ConA-based sensors. This study clearly demonstrates the feasibility of the proposed transdermal FRET-based sensor interrogation concept for glucose monitoring.

[1]  A. Turner,et al.  Ferrocene-mediated enzyme electrode for amperometric determination of glucose. , 1984, Analytical chemistry.

[2]  Michael M. Engelgau,et al.  Type 2 diabetes among North adolescents: An epidemiologic health perspective , 2000 .

[3]  Igor K Lednev,et al.  Photonic crystal carbohydrate sensors: low ionic strength sugar sensing. , 2003, Journal of the American Chemical Society.

[4]  G. Edelman,et al.  Concanavalin A derivatives with altered biological activities. , 1973, Proceedings of the National Academy of Sciences of the United States of America.

[5]  H. Dautzenberg,et al.  Viscosimetric affinity assay. , 1996, Analytical biochemistry.

[6]  O. Rolinski,et al.  Near-infrared fluorescence lifetime assay for serum glucose based on allophycocyanin-labeled concanavalin A. , 2001, Analytical biochemistry.

[7]  M. Shults,et al.  A subcutaneous glucose sensor with improved longevity, dynamic range, and stability of calibration. , 2000, Diabetes care.

[8]  Y. Ito,et al.  Interferon induction in mouse spleen cells by mitogenic and nonmitogenic lectins. , 1984, Journal of immunology.

[9]  Michael J. McShane,et al.  Variable Selection in Multivariate Calibration of a Spectroscopic Glucose Sensor , 1997 .

[10]  L. S. Kind,et al.  Concanavalin A in vivo: Induction of Hemorrhagic Skin Lesions (Arthus-Like Reactions) in Mice , 1968, Science.

[11]  U. Haueter,et al.  Clinical performance of a continuous viscometric affinity sensor for glucose. , 2004, Diabetes technology & therapeutics.

[12]  E. O’Neill,et al.  T cell activation-associated hepatic injury: mediation by tumor necrosis factors and protection by interleukin 6 , 1994, The Journal of experimental medicine.

[13]  J. Schultz,et al.  A fluorescence affinity hollow fiber sensor for continuous transdermal glucose monitoring. , 2000, Analytical chemistry.

[14]  Kaiming Ye,et al.  Genetic engineering of an allosterically based glucose indicator protein for continuous glucose monitoring by fluorescence resonance energy transfer. , 2003, Analytical chemistry.

[15]  Michael J. McShane,et al.  Glucose-Sensitive Nanoassemblies Comprising Affinity-Binding Complexes Trapped in Fuzzy Microshells , 2004, Journal of Fluorescence.

[16]  M. Leist,et al.  A novel mechanism of murine hepatocyte death inducible by concanavalin A. , 1996, Journal of hepatology.

[17]  A. Wendel,et al.  Concanavalin A hepatotoxicity in mice: Tumor necrosis factor–mediated organ failure independent of caspase‐3–like protease activation , 1999, Hepatology.

[18]  H. Heise,et al.  Noninvasive Blood Glucose Assay by Near-Infrared Diffuse Reflectance Spectroscopy of the Human Inner Lip , 1993 .

[19]  A. Wendel,et al.  A T cell-dependent experimental liver injury in mice inducible by concanavalin A. , 1992, The Journal of clinical investigation.

[20]  S. Daunert,et al.  Fluorescence Glucose Detection: Advances Toward the Ideal In Vivo Biosensor , 2004, Journal of Fluorescence.

[21]  Th. Förster.  Zwischenmolekulare Energiewanderung und Fluoreszenz , 1948 .

[22]  L. Lanier,et al.  Lectin-dependent and anti-CD3 induced cytotoxicity are preferentially mediated by peripheral blood cytotoxic T lymphocytes expressing Leu-7 antigen. , 1986, Journal of immunology.

[23]  M A Arnold,et al.  Strategies for coupling digital filtering with partial least-squares regression: application to the determination of glucose in plasma by Fourier transform near-infrared spectroscopy. , 1993, Analytical chemistry.

[24]  E. Möller,et al.  CONTACT-INDUCED CYTOTOXICITY BY LYMPHOID CELLS CONTAINING FOREIGN ISOANTIGENS. , 1965, Science.

[25]  D. S. Letbetter,et al.  Surface-immobilized dextran limits cell adhesion and spreading. , 2000, Biomaterials.

[26]  J. Tuomilehto,et al.  Incidence of childhood type 1 diabetes worldwide. Diabetes Mondiale (DiaMond) Project Group. , 2000, Diabetes care.

[27]  T von Woedtke,et al.  Implantable Glucose Sensors: Comparison between in Vitro and in Vivo Kinetics , 1991, The International journal of artificial organs.

[28]  S. Toyabe,et al.  Requirement of IL-4 and liver NK1+ T cells for concanavalin A-induced hepatic injury in mice. , 1997, Journal of immunology.

[29]  P. Vonk,et al.  Microdialysis of Glucose in Subcutaneous Adipose Tissue up to 3 Weeks in Healthy Volunteers , 1998, Diabetes Care.

[30]  J. Schultz,et al.  Affinity Sensor: A New Technique for Developing Implantable Sensors for Glucose and Other Metabolites , 1982, Diabetes Care.

[31]  J. Pickup,et al.  Developing glucose sensors for in vivo use. , 1993, Trends in biotechnology.

[32]  Binghe Wang,et al.  Progress in Boronic Acid-Based Fluorescent Glucose Sensors , 2004, Journal of Fluorescence.

[33]  G. Edelman,et al.  Activation of B lymphocytes by locally concentrated concanavalin A , 1972, European journal of immunology.

[34]  Jerome S. Schultz,et al.  Competitive-binding assay method based on fluorescence quenching of ligands held in close proximity by a multivalent receptor , 1997 .

[35]  S. Massia,et al.  Immobilized RGD peptides on surface-grafted dextran promote biospecific cell attachment. , 2001, Journal of biomedical materials research.

[36]  M. Manns,et al.  Concanavalin A-induced liver cell damage: activation of intracellular pathways triggered by tumor necrosis factor in mice. , 1998, Gastroenterology.

[37]  Joseph R. Lakowicz,et al.  Optical assay for glucose based on the luminescnence decay time of the long wavelength dye Cy5™. , 1997, Sensors and actuators. B, Chemical.

[38]  G L Coté,et al.  A fluorescence-based glucose biosensor using concanavalin A and dextran encapsulated in a poly(ethylene glycol) hydrogel. , 1999, Analytical chemistry.

[39]  E. V. Thomas,et al.  Noninvasive glucose monitoring in diabetic patients: a preliminary evaluation. , 1992, Clinical chemistry.

[40]  S. Garg,et al.  Improved glucose excursions using an implantable real-time continuous glucose sensor in adults with type 1 diabetes. , 2004, Diabetes care.

[41]  Ashok Gowda,et al.  Fluorescence resonance energy transfer-based near-infrared fluorescence sensor for glucose monitoring. , 2004, Diabetes technology & therapeutics.

[42]  Sohrab Mansouri,et al.  A Miniature Optical Glucose Sensor Based on Affinity Binding , 1984, Bio/Technology.

[43]  Peter G Jacobs,et al.  Feasibility of continuous long-term glucose monitoring from a subcutaneous glucose sensor in humans. , 2004, Diabetes technology & therapeutics.

[44]  W Kenneth Ward,et al.  Vascularizing the tissue surrounding a model biosensor: how localized is the effect of a subcutaneous infusion of vascular endothelial growth factor (VEGF)? , 2003, Biosensors & bioelectronics.

[45]  D. J. Harrison,et al.  Performance of subcutaneously implanted needle-type glucose sensors employing a novel trilayer coating. , 1993, Analytical chemistry.

[46]  M. Tyan.  In Vivo Toxicity of Concanavalin A 1 , 1974, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine.

[47]  P. Pereira,et al.  Modulation of cytolytic T cell function by lectins. , 1985, Journal of immunology.

[48]  D. Gough,et al.  Application of Chronic Intravascular Blood Glucose Sensor in Dogs , 1990, Diabetes.

[49]  F. Sternberg,et al.  On line continuous monitoring of subcutaneous tissue glucose in men by combining portable glucosensor with microdialysis , 1992, Diabetologia.

[50]  David L. Meadows,et al.  Design, manufacture and characterization of an optical fiber glucose affinity sensor based on an homogeneous fluorescence energy transfer assay system , 1993 .

[51]  J. Hall,et al.  T cell mitogens and polyclonal B cell activators. , 1987, Methods in enzymology.

[52]  J. DeSesso,et al.  Lectin teratogenesis. II: Demonstration of increased binding of concanavalin A to limb buds of rabbit embryos during the teratogenically sensitive period. , 1989, Teratology.